Our infectious disease specialists provide consult services to Seattle Cancer Care Alliance (SCCA) patients. Clinical services are provided at both inpatient (University of Washington Medical Center) and outpatient settings (SCCA outpatient facility located on the Fred Hutch campus).
IDS faculty physicians pursue a team approach to providing exceptional patient care, working closely with hematologists and oncologists on individual treatment plans for patients. Our researcher physicians also oversee critical quality-improvement initiatives related to infectious diseases, including the development of standard practice guidelines and other clinical care guidelines in infection control and antibiotics management.
With a background in hematopoetic cell transplant, Bhattacharyya is applying that knowledge to working with patients with infectious disease issues while continuing to provide thorough and compassionate care.
Dr. Boeckh studies infections in the immunocompromised host, especially diagnosis, prevention and treatment of CMV, VZV, BK virus, adenovirus and respiratory virus infections.
Dr. Boonyaratanakornkit studies the epidemiology and immunology of respiratory viral infections. His research is focused on developing diagnostics, vaccines, and therapeutics against respiratory viruses.
Dr. Casper's focus is on the transmission, progression and treatment of infection-associated cancers.
Dr. Corey's focus is on treating and diagnosing infectious diseases of the immunocompromised patient.
Dr. Duke studies viral infections that affect immunocompromised patients, using mathematical modeling. She is currently working on models of CMV infection in allogeneic transplant patients and cure strategies for HIV.
Dr. Ford is interested in the care and treatment of infections in immunocompromised patients.
Dr. Fredricks' focus is on the use of molecular methods for the diagnosis of bacterial and fungal infections.
Dr. Geballe's focus is on the interactions between the cellular antiviral protein kinase R (PKR) and viral PKR antagonists expressed by human cytomegalovirus, and vaccinia virus.
Dr. Gulleen is interested in understanding the risk-factors, epidemiology, and and management of post-chemotherapy infections in cancer patients living in low-resource and tropical settings.
Dr. Hill specializes in treating viral infections in immunocompromised cancer patients.
Dr. Liu focuses on improving patient outcomes through antimicrobial stewardship and outpatient parenteral antimicrobial therapy programs, by promoting appropriate use of antibiotics and optimizing transitions of care.
As a physician assistant, Mattson provided care with kindness and respect while having a thorough knowledge of the patient’s infectious disease issues.
Dr. Pergam's focus is in the area of CMV and gastrointestinal systems in transplant and cancer patients.
Dr. Phipps is interested in human herpesvirus-8 (HHV-8) virology and pathogenesis of Karposi sarcoma (KS), the most common HIV-associated malignancy worldwide.
Dr. Schiffer is interested in describing the quantitative and dynamic features of human pathogens and immune responses.
So enjoys working and providing care for people of all ages and backgrounds. She brings her molecular biology education as well as her bone marrow transplant service experience to provide care for her patients.
Dr. Wald is interested in epidemiology, natural history, therapy and prevention of HSV and other herpesvirus infections, including the interactions between HSV and HIV.
As a physician assistant, Yoke’s goal is to create a space where patients and their loved ones feel comfortable enough to honestly discuss their goals of care from an Infectious Disease standpoint. She strives to provide evidence-based, compassionate, unbiased care for every patient she sees.